About
Introduction
My PhD project focuses on the mechanisms and prevention of cardiovascular toxicity of anti-cancer treatments, in particular angiogenesis inhibitors and immune checkpoint inhibitors. By combining preclinical and clinical research, I aim to minimize cardiovascular risk in cancer patients by gaining improved insight into the pathophysiology and to identify clinical risk factors for the occurrence of this toxicity.
Field(s) of expertise
-
Cardio-Oncology
-
Pharmacology
-
Hypertension
Education and career
In 2013 I started studying Medicine at the Erasmus University in Rotterdam. In 2016 I obtained my BSc in Medicine and started my first year of the MSc in Molecular Medicine Program. I obtained my MSc in Medicine in 2020 and my MSc in Molecular Medicine in 2021. Since 2020 I am working as a MD & PhD candidate (arts-promovendus) at the departments of Internal Medicine (Divisions of Pharmacology and Vascular Medicine) and Internal Oncology under supervision of dr. Versmissen, prof. Mathijssen and prof. Danser.
Publications
A complete overview of publications can be found on Pubmed.
Teaching activities
Educational activities include teaching for the Minor “Toxic” (week on pharmacovigilance and cardio-oncology) and education on pharmacology to medical students.
Scholarships, grants, and awards
Awards
-
Gert van Montfransprijs 2021 – Nederlandse Hypertensie Vereniging (NHV)
-
Paul Dudley White International Scholar Award 2021 – American Heart Association (AHA)
